The Pharmacokinetics of Subcutaneously Administered Recombinant Human Ciliary Neurotrophic Factor (rHCNTF) in Patients with Amyotrophic Lateral Sclerosis
View Full Paper
Ask AI
Bookmark
Share
Discussion
Loading...
Member takes
Implication
Key Points
Key points are not available for this paper at this time.